Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Curated Information Page
PubMed Id: 23148217 
This page summarizes selected information from the article referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2012,40:D261-70). To learn more about the scope of PhosphoSitePlus®, click here.
Schulz EM, et al. (2012) Tropomyosin dephosphorylation results in compensated cardiac hypertrophy. J Biol Chem 287, 44478-89 23148217
Only sites from this record are displayed on this page. Click on the protein name to open the protein page, and on the RSD number to open the site page. For the complete dataset, click the download button, on the right.
Download Sites

S16-gl - PLB (mouse)
Orthologous residues
PLB (human): S16‑gl, PLB (mouse): S16‑gl, PLB (rat): S16‑gl, PLB (rabbit): S16‑gl, PLB (pig): S16‑gl, PLB (dog): S16‑gl
Upstream Regulation
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
increase Transgenic (S283A)

T17-p - PLB (mouse)
Orthologous residues
PLB (human): T17‑p, PLB (mouse): T17‑p, PLB (rat): T17‑p, PLB (rabbit): T17‑p, PLB (pig): T17‑p, PLB (dog): T17‑p
Upstream Regulation
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
no change compared to control Transgenic (S283A)

S23-p - TNNI3 (mouse)
Orthologous residues
TNNI3 (human): S23‑p, TNNI3 (mouse): S23‑p, TNNI3 (rat): S23‑p, TNNI3 (rabbit): S22‑p, TNNI3 (dog): S23‑p, TNNI3 (cow): S24‑p
Upstream Regulation
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
no change compared to control Transgenic (S283A)

S24-p - TNNI3 (mouse)
Orthologous residues
TNNI3 (human): S24‑p, TNNI3 (mouse): S24‑p, TNNI3 (rat): S24‑p, TNNI3 (rabbit): S23‑p, TNNI3 (dog): S24‑p, TNNI3 (cow): S25‑p
Upstream Regulation
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
no change compared to control Transgenic (S283A)

S283-p - TPM1 (mouse)
Orthologous residues
TPM1 (human): S283‑p, TPM1 iso2 (human): , TPM1 iso3 (human): , TPM1 iso6 (human): S283‑p, TPM1 (mouse): S283‑p, TPM1 iso2 (mouse): , TPM1 iso3 (mouse): , TPM1 iso4 (mouse): , TPM1 iso10 (mouse): , TPM1 (rat): S283‑p, TPM1 (rabbit): S283‑p, TPM1 (pig): S283‑p
Characterization
 Methods used to characterize site in vivo mutation of modification site
 Relevant cell lines - cell types - tissues:  heart [TPM1 (mouse), transgenic]
 Cellular systems studied:  tissue
 Species studied:  mouse
 Comments:  S283A mutant
Downstream Regulation
 Comments:  modulate the development of cardiac hypertrophy


Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.